With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Oncogenic RAS in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Innovation Grants||2018||Massachusetts|
|Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1||Northwestern University (Illinois) / Zibo Zhao, PhD||Young Investigator Grants||2018||Illinois|
|Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor||Ann & Robert H. Lurie Children's Hospital of Chicago / Rintaro Hashizume, MD/PhD||Reach Grants||2018||Illinois|
|Molecular Landscape for Targeted Therapy in Retinoblastoma||University of Miami / James Harbour, MD||Innovation Grants||2018||Florida|
|Surviving Cancer CAMPetently: Evidence-based Care Delivered at Family Camp||Nemours A.I. duPont Hospital for Children / Melissa Alderfer, PhD||Psychosocial Family Impact Grant||2018||Delaware|
|Enhancing Communication about Sexual and Reproductive Health between Oncology Clinicians and Adolescent and Young Adults||Connecticut Children's Medical Center / Dr. Natasha Frederick, PhD||Psychosocial Launch Grant||2018||Connecticut|
|Endocrine Disrupting Pesticides, Neonatal Hormones and Risk of Testicular Germ Cell Tumors||University of California Berkeley / Catherine Metayer, MD, PhD||Epidemiology Grants||2018||California|
|Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2018||California|
|Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors||University of California, Davis / Wolf-Dietrich Heyer, PhD||Innovation Grants||2018||California|
|Physical Properties of Drug-Resistant Leukemia Cells||Children's Hospital Los Angeles / Yong-mi Kim, MD/PhD||Innovation Grants||2018||California|